Nicotine Patch - Bioequivalence Study

NCT02089308 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Smokers

Interventions

DRUG: Test treatment : V0116 transdermal patch
DRUG: Reference treatment : Nicotine transdermal patch

Sponsor

Pierre Fabre Medicament